title: Challenges of thyroid cancer management in amiodarone-treated patients: a case report.
abstract: Thyroid carcinoma (TC) is the most common endocrine malignancy. Although the overall prognosis for patients with TC is good, up to 20-30% of patients have recurrent or persistent disease after conventional therapy by surgical resection and radioactive iodine (RAI). Amiodarone is a highly efficient anti-arrhythmic drug with a very long half-life, so it may interfere with RAI many months after the drug withdrawal. This case report mirrors the challenges of thyroid cancer management in an amiodarone-treated patient.
authors.affiliation: Department of Endocrinology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
authors.forename: Mirela Sanda
authors.initials: MS
authors.lastname: Petrulea
authors.affiliation: Department of Endocrinology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
authors.forename: Codruta
authors.initials: C
authors.lastname: Lencu
authors.affiliation: Nuclear Medicine Department, Ion Chiricuta Institute of Oncology, Cluj-Napoca, Romania.
authors.forename: Doina
authors.initials: D
authors.lastname: Piciu
authors.affiliation: Department of Surgery, Ion Chiricuta Institute of Oncology, Cluj-Napoca, Romania.
authors.forename: Cosmin Ioan
authors.initials: CI
authors.lastname: Lisencu
authors.affiliation: Department of Endocrinology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
authors.forename: Carmen Emanuela
authors.initials: CE
authors.lastname: Georgescu
keywords: amiodarone; lymph nodes dissection; radioiodine; thyroid cancer